These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. Evins AE, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, Freudenreich O, Henderson DC, Schoenfeld DA, Rigotti NA, Goff DC. J Clin Psychopharmacol; 2007 Aug 24; 27(4):380-6. PubMed ID: 17632223 [Abstract] [Full Text] [Related]
14. Relationship between adherence to daily nicotine patch use and treatment efficacy: secondary analysis of a 10-week randomized, double-blind, placebo-controlled clinical trial simulating over-the-counter use in adult smokers. Shiffman S, Sweeney CT, Ferguson SG, Sembower MA, Gitchell JG. Clin Ther; 2008 Oct 24; 30(10):1852-8. PubMed ID: 19014840 [Abstract] [Full Text] [Related]
15. Plasma fibrinogen in ulcerative colitis: the effect of disease activity and nicotine therapy in a randomised controlled trial. Ingram JR, Rhodes J, Collins PW, Williams GT, Newcombe RG, Thomas GA. Dig Liver Dis; 2005 Nov 24; 37(11):832-7. PubMed ID: 16169302 [Abstract] [Full Text] [Related]